News & Perspective

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

May 16, 2011

May 16, 2011

World Health Assembly opens 64th session in Geneva

(CIDRAP News) – Delegates from 193 countries met today in Geneva at the start of the World Health Assembly (WHA), which will address several infectious disease topics, including a report from an independent pandemic review committee, a virus-sharing agreement, and the fate of the world's remaining smallpox virus stocks.

Apr 15, 2011

Apr 15, 2011

CDC: Flu continues steady retreat

(CIDRAP News) – Flu activity across the United States continued to show signs of slowing, the Centers for Disease Control and Prevention (CDC) said today.

For the eighth week in a row, the percentage of doctor's visits for flu-like illness dropped, falling to 1.4% from 1.6% the previous week, the CDC reported in its weekly update. All 10 of the CDC's regions stayed below their baseline flu-visit levels.

Feb 17, 2011

Feb 17, 2011

WHO sticks with current strains for next flu vaccine

(CIDRAP News) – Signaling that the current flu strains are likely to persist over the next several months, the World Health Organization (WHO) today recommended sticking with the current trio of vaccine strains for the Northern Hemisphere's next influenza season.

The WHO's vaccine strain advisory committee met on Feb 15 and 16 and released its recommendation on the WHO's Web site. The group recommends the following for next season's vaccine:

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»